Kevin J. McNamara
2021
In 2021, Kevin J. McNamara earned a total compensation of $11.7M as President and CEO at Chemed, a 2% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $90,263 |
|---|---|
| Non-Equity Incentive Plan | $3,293,994 |
| Option Awards | $3,566,649 |
| Salary | $1,383,667 |
| Stock Awards | $1,893,990 |
| Other | $1,431,059 |
| Total | $11,659,622 |
McNamara received $3.6M in option awards, accounting for 31% of the total pay in 2021.
McNamara also received $90.3K of change in pension value and nonqualified deferred compensation earnings, $3.3M in non-equity incentive plan, $1.4M in salary, $1.9M in stock awards and $1.4M in other compensation.
Rankings
In 2021, Kevin J. McNamara's compensation ranked 819th out of 12,415 executives tracked by ExecPay. In other words, McNamara earned more than 93.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 819 out of 12,415 | 93rd |
Division Services | 264 out of 2,290 | 89th |
Major group Health Services | 26 out of 252 | 90th |
Industry group Home Health Care Services | 1 out of 37 | 97th |
Industry Home Health Care Services | 1 out of 37 | 97th |
Source: SEC filing on April 8, 2022.
McNamara's colleagues
We found four more compensation records of executives who worked with Kevin J. McNamara at Chemed in 2021.